Vaccine Developers & Sponsors
Explore research and clinical trial portfolios across 64 vaccine manufacturers and biopharma sponsors worldwide.
GSK
Approved / Licensed: 2, Phase 3 Clinical Trial: 12, Discontinued / Inactive: 23
Sanofi
Phase 3 Clinical Trial: 7, Discontinued / Inactive: 13, Phase 2 Clinical Trial: 8
Merck
Approved / Licensed: 1, Phase 3 Clinical Trial: 3, Discontinued / Inactive: 15
Sinovac
Phase 3 Clinical Trial: 15, Discontinued / Inactive: 5, Phase 2 Clinical Trial: 2
Pfizer
Phase 3 Clinical Trial: 8, Approved / Licensed: 2, Discontinued / Inactive: 10
Moderna
Regulatory Submission Filed: 2, Approved / Licensed: 5, Phase 3 Clinical Trial: 5
BioNTech
Phase 3 Clinical Trial: 4, Phase 2 Clinical Trial: 2, Discontinued / Inactive: 3
CanSino Biologics
Phase 3 Clinical Trial: 5, Discontinued / Inactive: 2, Phase 2 Clinical Trial: 2
Novavax
Phase 3 Clinical Trial: 1, Approved / Licensed: 1, Discontinued / Inactive: 5
Serum Institute of India
Discontinued / Inactive: 1, Phase 3 Clinical Trial: 2, Phase 2 Clinical Trial: 3
Bavarian Nordic
Approved / Licensed: 1, Phase 3 Clinical Trial: 1, Discontinued / Inactive: 2
Valneva
Approved / Licensed: 1, Approved / Restricted: 1, Phase 3 Clinical Trial: 1
Vaxcyte
Phase 3 Clinical Trial: 2, Phase 2 Clinical Trial: 1, Phase 1 Clinical Trial: 1
Bharat Biotech
Phase 3 Clinical Trial: 1, Phase 2 Clinical Trial: 1, Discontinued / Inactive: 1
Novartis Pharmaceuticals
Discontinued / Inactive: 1, Phase 2 Clinical Trial: 1
Centre Hospitalier Universitaire de Saint Etienne
Discontinued / Inactive: 1, Phase 3 Clinical Trial: 1
National Institute of Allergy and Infectious Diseases (NIAID)
Discontinued / Inactive: 1
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair
Phase 1 Clinical Trial: 1
Louisiana State University Health Sciences Center in New Orleans
Phase 3 Clinical Trial: 1